Could a vaccine and antibody shot free HIV patients from daily meds?
NCT ID NCT04983030
First seen Jan 12, 2026 · Last updated May 18, 2026 · Updated 19 times
Summary
This study tests whether a special vaccine plus three lab-made antibodies can help people with HIV control the virus without taking daily antiretroviral therapy (ART). About 36 adults with well-controlled HIV will receive the vaccine and antibodies or a placebo, then temporarily stop their regular HIV meds to see if the virus stays low. The goal is to find a safer, easier way to manage HIV long-term, but participants may still need some medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02115, United States
-
Orlando Immunology Center
Orlando, Florida, 32803, United States
-
UCLA CARE (Center for AIDs Research and Education)
Los Angeles, California, 90035, United States
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
-
University of Washington Positive Research
Seattle, Washington, 98104, United States
-
Washington University Clinical Trials Unit
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.